Displaying 1 - 3 of 3 for Cancer - Myeloma
- CHARKALL Study (H-23574)
- Patients have a type of cancer called NHL, Multiple Myeloma (MM) or CLL. The lymphoma, MM or CLL has come back or has not gone away after treatment. This is a gene transfer research study using special immune cells.
- TACTAM Study (H-35626)
- The purpose of this study is to find the largest safe dose of TAA-specific CTLs, to learn what the side effects are, and to see whether this therapy might help patients with multiple myeloma.
- Treatment for Patients With Newly Diagnosed Multiple Myeloma (H-35330)
- This randomized phase III trial studies bortezomib, lenalidomide, and dexamethasone to see how well it works compared to carfilzomib, lenalidomide, and dexamethasone in treating patients with newly diagnosed multiple myeloma.